Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A - Fossmark, R; Sørdal, Ø; Jianu, C S (Aliment Pharmacol Ther, 2012)
(11-12):